CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 48 enrolled
Drug / intervention
STOP-HPV communication interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03599557
NCT03599557N/ACompleted
CompareCT.gov

Improving HPV Vaccination Delivery in Pediatric Primary Care: The STOP-HPV Trial 1. Comparison of Communication Skills and Standard of Care for Uptake of the HPV Vaccine

University of California, Los Angeles·interventional·Posted Jul 26, 2018·Updated Jul 12, 2024

In Brief

A clinical study evaluating STOP-HPV communication intervention for Immunization and Vaccination. Completed, enrolled 48 participants across 1 site.

Detailed Summary

Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectiveness) of training providers on HPV vaccine communication to reduce MOs and increase HPV vaccination rates.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsImmunization, Vaccination
CountriesUnited States
CollaboratorsChildren's Hospital of Philadelphia, American Academy of Pediatrics, University of Pennsylvania, National Institutes of Health (NIH), National Cancer Institute (NCI), University of Rochester

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 26, 2018
Enrollment StartAug 7, 2018
Primary CompletionJul 30, 2019
Study CompletionOct 21, 2019
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 7.9 years ago

Interventions

STOP-HPV communication interventionbehavioral

This intervention will be communication skills training.